SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,305,000 | -16.7% | 17,429 | -3.7% | 0.01% | -20.0% |
| Q4 2020 | $1,566,000 | -41.3% | 18,098 | -58.6% | 0.02% | -48.3% |
| Q3 2020 | $2,669,000 | +203.0% | 43,671 | +106.2% | 0.03% | +163.6% |
| Q2 2020 | $881,000 | -89.2% | 21,177 | -92.5% | 0.01% | -92.0% |
| Q1 2020 | $8,150,000 | -58.0% | 283,786 | +5.6% | 0.14% | -49.3% |
| Q4 2019 | $19,400,000 | -48.1% | 268,733 | +0.9% | 0.27% | -52.0% |
| Q3 2019 | $37,356,000 | +1099.6% | 266,280 | +1465.7% | 0.56% | +157.8% |
| Q2 2019 | $3,114,000 | – | 17,007 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |